Skip to search formSkip to main contentSkip to account menu

anti-CD7 immunotoxin

Known as: Anti CD7 immunotoxin, Immunotoxin, anti CD7, immunotoxin, anti-CD7 
A toxin linked to an anti-CD7 antibody.
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Immunotoxins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Flow Cytometric Screening of Novel Antigen Expression in T- ALL
Abstract 1436 Background: The distinction in antigen expression between normal T cells and T-ALL is currently limited by a narrow… 
2003
2003
Hematopoietic progenitor cell laboratory manual. Ex-vivoselective depletion of alloreactive donor T lymphocytes usingthe anti-CD25 immunotoxin RFT5-SMPT-dgA
Hematopoietic progenitor cell laboratory manual. Ex-vivo selective depletion of alloreactive donor T lymphocytes using the anti… 
1996
1996
Bispecific anti-CD3/CD4-CRM9: A novel bifunctional immunotoxin targeting CD3+CD4+T cells
Highly Cited
1996
Highly Cited
1996
Treatment of advanced solid tumors with immunotoxin LMB–1: An antibody linked to Pseudomonas exotoxin
Immunotoxin LMB–1 is composed of monoclonal antibody B3 chemically linked to PE38, a genetically engineered form of Pseudomonas… 
Review
1996
Review
1996
Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
This study reviews results of a radiation-free preparative regimen consisting of busulfan and cyclophosphamide in 65 unrelated… 
Highly Cited
1995
Highly Cited
1995
Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours.
The immunotoxin BU12-SAPORIN was constructed by covalently coupling the single-chain ribosome-inactivating protein saporin to the… 
1995
1995
Efficacy of compartmental administration of immunotoxin LMB-1 (B3-LysPE38) in a rat model of carcinomatous meningitis.
LMB-1 (B3-LysPE38) is an immunotoxin composed of the tumor-reactive monoclonal antibody B3 and a genetically engineered form of… 
1994
1994
Isolation and characterization of CD6- T cells from peripheral blood.
Antibodies to the CD6 Ag have been described as having pan-T cell reactivity. We have recently demonstrated, however, that after… 
1992
1992
An anti‐mucin immunotoxin BrE‐3‐ricin A‐chain is potently and selectively toxic to human small‐cell lung cancer
Monoclonal antibodies (MAbs) known to recognize epithelial mucin or defined carbohydrate structures present on mucin molecules… 
1992
1992
In vivo T-cell ablation by a holo-immunotoxin directed at human CD3.
We have evaluated the in vivo efficacy of anti-CD3-CRM9, a holo-immunotoxin constructed with a diphtheria toxin binding-site… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)